SNTI peer analysis
Senti Biosciences (SNTI) against its competitors: price, today's move, 1-year return and market value side by side.
- SNTI's peers: ALGS (Aligos Therapeutics), CUE (Cue Biopharma), CVM (Cel-Sci), GNTA (Genenta Science), IPSC (Century Therapeutics), KPTI (Karyopharm Therapeutics), MDCX (Medicus Pharma), XFOR (X4 Pharmaceuticals).
SNTI and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALGS Aligos Therapeutics | $1.25 | -3.85% | -84.81% | $7.81M |
| CUE Cue Biopharma | $4.20 | -6.67% | -75.87% | $35.11M |
| CVM Cel-Sci | $1.47 | 6.52% | -76.37% | $25.86M |
| GNTA Genenta Science | $0.98 | 20.62% | -61.52% | – |
| IPSC Century Therapeutics | $1.16 | -12.46% | 123.54% | $209.84M |
| KPTI Karyopharm Therapeutics | $0.02 | -56.50% | -99.68% | $394.66K |
| MDCX Medicus Pharma | $1.16 | -16.55% | -98.96% | $1.66M |
| XFOR X4 Pharmaceuticals | $3.00 | 1.35% | -17.81% | $306.34M |
| SNTI Senti Biosciences | $2.05 | -26.52% | -96.47% | $1.93M |